New UNAIDS report highlights progress in the AIDS response in Africa
29 May 2013. Related: Treatment access.
2013
Indian Supreme Court delivers verdict in Novartis case: decision safeguards access to affordable medicines and prevents abusive patenting of medicines
29 May 2013. Related: Treatment access.
FDA approval of generic ARVs
29 May 2013. Related: Treatment access.
EU approves four-in-one Stribild
29 May 2013. Related: Antiretrovirals.
FDA delays decision for elvitegravir and cobicistat
29 May 2013. Related: Antiretrovirals.
EU approval for raltegravir in children aged 2 years and older
29 May 2013. Related: Antiretrovirals, Paediatric care.
FDA update label for paediatric efavirenz and capsule sprinkle formulation
29 May 2013. Related: Antiretrovirals, Paediatric care.
Cobicistat compared to ritonavir to boost atazanavir in treatment naive patients
29 May 2013. Related: Antiretrovirals.
Osteonecrosis in HIV positive patients is associated with increased levels of CRP and D-dimer
29 May 2013. Related: Side effects.
No impact of ART on progression or regression of anal squamous intraepithelial lesions
29 May 2013. Related: Side effects.
Incidence of cancers in Australian observational cohort
29 May 2013. Related: Side effects.
Searching for HIV in Timothy Brown, the Berlin Patient
29 May 2013. Related: Cure-related research, Basic science and immunology.
Reviewing strategies for draining HIV reservoirs
29 May 2013. Related: Cure-related research, Basic science and immunology.
Can a route to broadly neutralising antibodies be traced?
29 May 2013. Related: Basic science and immunology.
Life insurance for HIV positive people on stable treatment
29 May 2013. Related: Other news.
Conference abstract: BHIVA 2013
29 May 2013. Related: On the web.
PLoS Medicine : free full text online articles
29 May 2013. Related: On the web.
Volume 14 Number 5/6 May/June 2013 PDF
28 May 2013. Related: PDFs.
Volume 14 Number 3/4 March/April 2013 PDF
1 April 2013. Related: PDFs.
Volume 14 Number 3/4 March/April 2013
1 April 2013. Related: Editorial.
20th Conference on Retroviruses and Opportunistic Infections (CROI) 3-6 March 2013, Atlanta
1 April 2013. Related: Conference reports.
ARV pipeline: dolutegravir, TAF (GS-7340), MK-1439 and cenicriviroc
1 April 2013. Related: Conference reports, Antiretrovirals.
ARV pipeline: long-acting formulations of rilpivirine, GSK-744 and nanoformulations
1 April 2013. Related: Conference reports, Antiretrovirals.
Five-year results from the AntiRetroviral Research for Watoto (ARROW) Trial
1 April 2013. Related: Conference reports, Antiretrovirals, Paediatric care.
Comparison of ritonavir-boosted lopinavir or NNRTI ART and PK with antimalarials in Ugandan children
1 April 2013. Related: Conference reports, Antiretrovirals, Paediatric care.
Pharmacokinetics and acceptability of lopinavir/ritonavir sprinkles in children aged 1 to 4 years
1 April 2013. Related: Conference reports, Antiretrovirals, Paediatric care, PK and drug interactions.
Pharmacokinetics of currently available antiretroviral options for young children
1 April 2013. Related: Conference reports, Antiretrovirals, Paediatric care, PK and drug interactions.
Safety of transplacental raltegravir in neonates and washout pharmacokinetics
1 April 2013. Related: Conference reports, Antiretrovirals, Pregnancy, PK and drug interactions.
Tenofovir use in children
1 April 2013. Related: Conference reports, Antiretrovirals, Paediatric care.
ddI resistance in South African children failing an abacavir or d4T based first-line regimen
1 April 2013. Related: Conference reports, Antiretrovirals, Paediatric care, Drug resistance.
Statin use in HIV positive people
1 April 2013. Related: Conference reports, Side effects.
RIFAQUIN study demonstrates once-weekly dosing during follow-up phase of TB treatment
1 April 2013. Related: Conference reports, Coinfections and complications, TB coinfection.
Combining Xpert and LAM urine testing improves TB diagnostic sensitivity
1 April 2013. Related: Conference reports, Diagnostics, Coinfections and complications, TB coinfection.
Deferring ART by four weeks reduces mortality in patients diagnosed with cryptococcal meningitis
1 April 2013. Related: Conference reports, Coinfections and complications.
Monthly injection protects macaques from rectal exposure: results should fast-track human studies for advanced PrEP options
1 April 2013. Related: Conference reports, HIV prevention and transmission.
Tenofovir DF ring protects macaques from vaginal exposure
1 April 2013. Related: Conference reports, HIV prevention and transmission.
VOICE study reports low adherence as reason for lack of efficacy for PrEP: anal sex common in African heterosexuals
1 April 2013. Related: Conference reports, HIV prevention and transmission.
Further studies on how male circumcision may reduce HIV transmission
1 April 2013. Related: Conference reports, HIV prevention and transmission.
Report of a functional cure in an HIV infected infant
1 April 2013. Related: Conference reports, Paediatric care, Cure-related research.
Dietary requirements changed in Europe for fixed dose combination rilpivirine/tenofovir/FTC (Eviplera)
1 April 2013. Related: Antiretrovirals, PK and drug interactions.
EU adopts positive opinion for decision on regulatory approval of Quad
1 April 2013. Related: Antiretrovirals.
Gilead Sciences announces fourth quarter and full year 2012 financial results
1 April 2013. Related: Antiretrovirals.
ViiV stops development of NNRTI lersivirine
1 April 2013. Related: Antiretrovirals.
Nelfinavir non-renewal of marketing authorisation in the EU
1 April 2013. Related: Antiretrovirals.
Why the “when to start” question is complex and informed by limited evidence: a response to Dr Myron Cohen
1 April 2013. Related: Treatment strategies, Guidelines.
US (DHHS) ARV guidelines updated (February 2013): moderate recommendation to treat at CD4 count >500 is based only on expert opinion
1 April 2013. Related: Guidelines.
No impact of ART on progression or regression of anal squamous intraepithelial lesions
1 April 2013. Related: Side effects.
Osteonecrosis in HIV positive patients is associated with increased levels of CRP and D-dimer
1 April 2013. Related: Side effects.
Cognitive disorders are common in French cohort but are not HIV-related
1 April 2013. Related: Side effects.
Once-daily option for paediatric use of darunavir/ritonavir
1 April 2013. Related: Paediatric care.
Tuberculosis MVA85A vaccine trial shows lack of efficacy in infants
1 April 2013. Related: TB coinfection.
CD4 T cells specific for different pathogens vary in susceptibility to HIV infection
1 April 2013. Related: Basic science and immunology.
START study increases sample size: additional 600 participants to be older than 35
1 April 2013. Related: Antiretrovirals, Treatment strategies.
US Senate supports bill to allow HIV positive organ donations to HIV positive recipients
1 April 2013. Related: Other news.
Update on AllTrials campaign for publication of full research results: PhRMA unhappy but GSK sign up
1 April 2013. Related: Other news.
Volume 14 Number 1/2 January/February 2013
1 February 2013. Related: Editorial.
WHO statement: generic antiretroviral therapy is safe and effective
1 February 2013. Related: Treatment alerts, Antiretrovirals.
3rd International Workshop on HIV and Women, 14-15 January 2013, Toronto
1 February 2013. Related: Conference reports.
Nevirapine-containing ART does not reduce combined oral contraceptive effectiveness
1 February 2013. Related: Conference reports, Antiretrovirals, Women's health.
Minimal risk of sexual HIV transmission for heterosexual couples when the HIV positive partner has an undetectable viral load
1 February 2013. Related: Conference reports, Women's health, HIV prevention and transmission.
Differences by age for women in response to initial ART: meta-analysis from clinical studies submitted to the FDA
1 February 2013. Related: Conference reports, Antiretrovirals, Women's health.
Lopinavir/ritonavir in pregnancy: results from a systematic review
1 February 2013. Related: Conference reports, Antiretrovirals, Women's health, Pregnancy.
Possible mechanisms for adverse pregnancy outcomes in HIV positive women
1 February 2013. Related: Conference reports, Women's health, Pregnancy.
43rd Union World Conference on Lung Health, 13-17 November 2012, Kuala Lumpur, Malaysia.
1 February 2013. Related: Conference reports.
Paediatric TB: glimpses of PK data and a potential new approach to drug development
1 February 2013. Related: Conference reports, Paediatric care, PK and drug interactions, TB coinfection.